Key points are not available for this paper at this time.
Letters3 April 2012Screening for Prostate CancerRoger Chou, MD and Jennifer M. Croswell, MD, MPHRoger Chou, MDFrom Oregon Health ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-8. PMID: 19297566 CrossrefMedlineGoogle Scholar2. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-9. PMID: 19297565 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Oregon Health & Science University, Portland, OR 97239, and Agency for Healthcare Research and Quality, Rockville, MD 20850.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1085. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoScreening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force Roger Chou , Jennifer M. Croswell , Tracy Dana , Christina Bougatsos , Ian Blazina , Rongwei Fu , Ken Gleitsmann , Helen C. Koenig , Clarence Lam , Ashley Maltz , J. Bruin Rugge , and Kenneth Lin Screening for Prostate Cancer Sigrid Carlsson , Andrew Vickers , Hans Lilja , and Jonas Hugosson Screening for Prostate Cancer M'Liss A. Hudson Screening for Prostate Cancer Murray S. Feldstein Metrics 3 April 2012Volume 156, Issue 7Page: 540KeywordsCancer screeningCancer treatmentPopulation statisticsProstate cancerProstate diseasesQuality of lifeRadiation therapySurgery ePublished: 3 April 2012 Issue Published: 3 April 2012 Copyright & PermissionsCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Chou et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: